Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance.
about
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cellsTargeting Aggressive Cancer Stem Cells in GlioblastomaNF-κB and STAT3 in glioblastoma: therapeutic targets coming of ageBrain tumor stem cells: Molecular characteristics and their impact on therapyOvercoming therapeutic resistance in glioblastoma: the way forwardImproving the radiosensitivity of radioresistant and hypoxic glioblastoma.Cucurbitacin I induces protective autophagy in glioblastoma in vitro and in vivoTranscription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.Potential therapeutic implications of cancer stem cells in glioblastomaPrognostic significance of erythropoietin in pancreatic adenocarcinomaErythropoietin and cancer: the unintended consequences of anemia correctionStat and interferon genes identified by network analysis differentially regulate primitive and definitive erythropoiesisSilencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastropheErythropoietin in stroke therapy: friend or foeScram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5.Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneityPreferential Iron Trafficking Characterizes Glioblastoma Stem-like CellsThe implications of cancer stem cells for cancer therapy.On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cellsFar-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibodyTargeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.Intranasal erythropoietin therapy in nervous system disorders.Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.Targeting adaptive glioblastoma: an overview of proliferation and invasion.miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway.Hypothermia stimulates glioma stem spheres to spontaneously dedifferentiate adjacent non-stem glioma cells.Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells.Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiformeImpact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome.
P2860
Q24293124-3A4391D4-728E-4B5E-B379-F865A4ACB7BCQ26799983-937B2D39-5A0C-4AD4-9254-367CFDBF9D85Q26830388-8D9A3061-2562-4116-B077-B31F10363F84Q27003138-6F7ECEF6-47A6-4565-9801-459E4F4977AAQ29248396-AED9C306-A0B3-4713-BD89-6EFDC473718CQ30452219-86C0F219-743E-4BEF-B149-1DDFAE5C85FAQ33675791-F5F35826-22AD-42E0-812D-7F2E9F5A3632Q33820278-8D678F4E-0703-449D-9C24-2428073B02A4Q33965491-93A8001A-6103-4DCD-92D9-C8B7FF2B1F2FQ33988762-9D66DAB3-D986-40D5-90A1-8260AC7DD990Q34488415-188E4B21-CD60-4C82-BF70-675706E18A33Q34723819-4EB99B13-D75D-47F9-8C44-0F00D7E5DEB6Q35273402-63D1FA29-47B4-4EE8-93DA-CD3237CD9BBEQ35548966-0F51F5CB-5E09-4A2C-B642-DA4F889FEFA2Q35823362-CE2F0B0B-53A9-4308-8CE6-1E25B815977FQ36020891-F0446F8D-1C98-4315-8F3E-C9A5B673BD53Q36282985-C340DADD-A8E1-4317-A575-06BE18E0DF90Q36538487-298F8CF8-2431-4F70-8D9E-B08EE7BBAB1EQ36544116-18919CE6-878A-4650-8653-9BE60168CA47Q37107771-C443C4DF-D353-428B-9689-1A7E80DAA513Q37599312-B90DAE87-F179-4BEA-BC7E-93E706A7FCF7Q37694434-F01718F7-0F5A-46F1-9969-60409D592A9EQ37818329-CEC5F94A-0F7C-455D-9061-ACCFE5A1F0D2Q37825821-38994660-7EC0-4487-BFB5-2D39802BAC7DQ38235930-933D966B-D94C-409C-9BC6-A1FED90E2FE7Q38891181-4288678B-BA21-4445-BCDB-78B47F04257DQ38955907-A50593A1-48C8-4780-8352-3F2D523418DAQ39600283-EBB8311B-BE00-4719-96F4-FC981249AA93Q41942436-02ED5307-626D-4E07-B023-8CEC52026BEBQ49273540-750C1B45-1240-46F4-BB45-F492234039A1
P2860
Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@ast
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@en
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@nl
type
label
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@ast
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@en
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@nl
prefLabel
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@ast
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@en
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@nl
P2093
P2860
P356
P1433
P1476
Erythropoietin Receptor Signal ...... Glioma Stem Cell Maintenance.
@en
P2093
Christine E Eyler
Jeremy N Rich
Justin D Lathia
Qiulian Wu
Yiting Cao
Zhizhong Li
P2860
P356
10.1177/1947601909356352
P577
2010-01-01T00:00:00Z